{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:31:13Z","timestamp":1772721073225,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,12,7]],"date-time":"2004-12-07T00:00:00Z","timestamp":1102377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1038\/sj.bjc.6602270","type":"journal-article","created":{"date-parts":[[2004,12,7]],"date-time":"2004-12-07T10:09:52Z","timestamp":1102414192000},"page":"60-71","source":"Crossref","is-referenced-by-count":14,"title":["A micro costing of NHS cancer genetic services"],"prefix":"10.1038","volume":"92","author":[{"name":"(The GenQuest research team)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G L","family":"Griffith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Tudor-Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,12,7]]},"reference":[{"issue":"21","key":"BF6602270_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","volume":"338","author":"LA Aaltonen","year":"1998","unstructured":"Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomak P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A, Percesepe A, Ahtola H, Harkonen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E (1998) Incidence of hereditary nonpolyposis cancer and the feasibility of molecular screening for the disease. N Engl J Med 338 (21): 1481\u20131487","journal-title":"N Engl J Med"},{"key":"BF6602270_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/BF02895156","volume":"19","author":"J Audrain","year":"1998","unstructured":"Audrain J, Schwarts MD, Lerman C, Hughes C, Peshkin BN, Biesecker B (1998) Psychological distress in women seeking genetic counselling for breast ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 19: 370\u2013377","journal-title":"Ann Behav Med"},{"key":"BF6602270_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmg.37.3.197","volume":"37","author":"K Brain","year":"2000","unstructured":"Brain K, Gray J, Norman P, Parsons E Clarke A, Rogers C, Mansel R, Harper P (2000) Why do women attend familial breast cancer clinics? J Med Genet 37: 1\u20135","journal-title":"J Med Genet"},{"key":"BF6602270_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/jnci\/87.15.1131","volume":"87","author":"ML Brown","year":"1995","unstructured":"Brown ML, Kessler LG (1995) The use of gene tests to detect hereditary predisposition to cancer: Economic considerations. J Natl Cancer Inst 87: 1131\u20131136","journal-title":"J Natl Cancer Inst"},{"key":"BF6602270_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/(SICI)1097-0215(19960220)69:1<55::AID-IJC14>3.0.CO;2-J","volume":"69","author":"ML Brown","year":"1996","unstructured":"Brown ML, Kessler LG (1996) Use of gene tests to detect hereditary predisposition to cancer: What do we know about cost-effectiveness? Int J Cancer 69: 55\u201357","journal-title":"Int J Cancer"},{"key":"BF6602270_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/A:1009463905057","volume":"9","author":"S Clarke","year":"2001","unstructured":"Clarke S, Bluman LG, Borstelmann N, Regan K, Winer EP, Rimer BK, Skinner CS (2001) Patient motivation, satisfaction and coping in genetic counseling and testing for BRCA1 and BRCA2. Journal of Genetic Counseling 9: 219\u2013235","journal-title":"Journal of Genetic Counseling"},{"key":"BF6602270_CR7","unstructured":"Committee for Medical Genetics Workload Units Working Group (2002) CMGS Workload Units: Proposed Scheme. The Committee for Medical Genetics"},{"key":"BF6602270_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.bjc.6601170","volume":"89","author":"A Fry","year":"2003","unstructured":"Fry A, Cull A, Appleton S, Rush R, Holloway S, Gorman D, Cetnarskyj R, Thomas R, Campbnell J, Anderson E, Steel M, Porteous M, Campbell H (2003) A randomised control treial of breast cancer genetics services in South East Scotland: Psychologicxal impact. Br J Cancer 89: 653\u2013659","journal-title":"Br J Cancer"},{"key":"BF6602270_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/A:1009451213035","volume":"10","author":"KP Geer","year":"2001","unstructured":"Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S (2001) Factors influencing patients' decisions to decline cancer genetic counselling services. Journal of Genetic Counseling 10: 25\u201340","journal-title":"Journal of Genetic Counseling"},{"key":"BF6602270_CR10","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1038\/sj.bjc.6601792","volume":"90","author":"GL Griffith","year":"2004","unstructured":"Griffith GL, Edwards RT, Gray J (2004) Cancer Genetics Services: A Review of the Economic Evidence and Issues. Br J Cancer 90: 1697\u20131703","journal-title":"Br J Cancer"},{"issue":"3","key":"BF6602270_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1009468005966","volume":"9","author":"FJM Grosfeld","year":"2000","unstructured":"Grosfeld FJM, Lips CJM, Beemer FA, ten Kroode HFJ (2000) Who is at risk for psychological distress in genetic testing programs for hereditary cancer disorders? Journal of Genetic Counseling 9 (3): 253\u2013266","journal-title":"Journal of Genetic Counseling"},{"key":"BF6602270_CR12","volume-title":"UK Familial Ovarian Cancer Screening Study: Study Protocol","author":"I Jacobs","year":"2000","unstructured":"Jacobs I, Mackay J, Menon U, Skates S (2000) UK Familial Ovarian Cancer Screening Study: Study Protocol. Cancer Research UK and University College London Cancer Trials Centre \n                    http:\/\/www.ncrn.org.uk\/portfolio\/data.asp?ID=1069"},{"key":"BF6602270_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"SH Landis","year":"1999","unstructured":"Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin 49: 8\u201331","journal-title":"CA Cancer J Clin"},{"key":"BF6602270_CR14","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1006\/pmed.1997.0204","volume":"26","author":"C Lerman","year":"1997","unstructured":"Lerman C (1997) Translational behavioural research in cancer genetics. Preventative Medicine 26: S65\u2013S69","journal-title":"Preventative Medicine"},{"key":"BF6602270_CR15","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1200\/JCO.1998.16.5.1650","volume":"16","author":"C Lerman","year":"1998","unstructured":"Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Norad S, Lynch HT (1998) What you don't know can hurt you: adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who declined genetic testing. J Clin Oncol 16: 1650\u20131654","journal-title":"J Clin Oncol"},{"issue":"3","key":"BF6602270_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1037\/0022-006X.65.3.414","volume":"65","author":"C Lerman","year":"1997","unstructured":"Lerman C, Schwartz MD, Lin TH, Hughes C, Norad S, Lynch HT (1997) The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 65 (3): 414\u2013420","journal-title":"J Consult Clin Psychol"},{"key":"BF6602270_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/1097-0142(19840201)53:3+<612::AID-CNCR2820531306>3.0.CO;2-5","volume":"53","author":"HT Lynch","year":"1984","unstructured":"Lynch HT, Albano WA, Danes BS, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA, Tindall SL (1984) Genetic predisposition to breast cancer. Cancer 53: 612\u2013622","journal-title":"Cancer"},{"issue":"3","key":"BF6602270_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","volume":"40","author":"S Malanders","year":"2004","unstructured":"Malanders S, Ridderheim M, Masback A, Loman N, Kristoffersson U, Olsson H, Nibert M, Boirg A (2004) One in 10 ovarian cancer patients carry germline BRCA1 or BRCA2 mutations. Results of a prospective study in Southern Sweden. Eur J Cancer 40 (3): 422\u2013428","journal-title":"Eur J Cancer"},{"key":"BF6602270_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonnin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66\u201371","journal-title":"Science"},{"key":"BF6602270_CR20","volume-title":"Unit Costs of Health and Social Care","author":"A Netten","year":"2003","unstructured":"Netten A, Curtis L (2003) Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury"},{"issue":"Supplement 1","key":"BF6602270_CR21","first-page":"46","volume":"80","author":"BAJ Ponder","year":"1999","unstructured":"Ponder BAJ (1999) Costs, benefits and limitations of genetic testing for cancer risk. Br J Cancer 80 (Supplement 1): 46\u201350","journal-title":"Br J Cancer"},{"key":"BF6602270_CR22","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0277-9536(00)00248-3","volume":"52","author":"G Rees","year":"2001","unstructured":"Rees G, Fry A, Cul A (2001) A family history of breast cancer: women's experiences from a theoretical perspective. Soc Sci Med 52: 1433\u20131440","journal-title":"Soc Sci Med"},{"key":"BF6602270_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JLA, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700\u2013711","journal-title":"Am J Hum Genet"},{"key":"BF6602270_CR24","first-page":"682","volume":"127","author":"C Soravia","year":"1997","unstructured":"Soravia C, Bapat B, Cohen Z (1997) Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects. Schweiz Med Wochenschr 127: 682\u2013690","journal-title":"Schweiz Med Wochenschr"},{"key":"BF6602270_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1155\/1999\/564893","volume":"15","author":"M Steel","year":"1999","unstructured":"Steel M, Smyth E, Vasen H, Eccles D, Evans G, Moller P, Hodgson S, Stoppa-Lyonnet D, Chang-Claude J, Caligo M, Morrison P, Haites N (1999) Ethical, social and economic issues in familial breast cancer: A compilation of views from the E.C. Biomed II Demonstration project. Dis Markers 15: 125\u2013131","journal-title":"Dis Markers"},{"key":"BF6602270_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789\u2013792","journal-title":"Nature"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602270","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:13:39Z","timestamp":1684412019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["BF6602270"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602270","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,7]]}}}